← Evidence map

ArticleCureus2026

Stage IV Rectal Adenocarcinoma After Negative Multitarget Stool DNA-Fecal Immunochemical Test in a Symptomatic Patient: Misapplication of a Screening Test in a Diagnostic Context.

Yazan Omari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Stage IV Rectal Adenocarcinoma After Negative Multitarget Stool DNA-Fecal Immunochemical Test in a Symptomatic Patient: Misapplication of a Screening Test in a Diagnostic Context. | OpenQuestion